265 related articles for article (PubMed ID: 25433637)
21. RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells.
Luessen DJ; Hinshaw TP; Sun H; Howlett AC; Marrs G; McCool BA; Chen R
Neuropharmacology; 2016 Nov; 110(Pt A):297-307. PubMed ID: 27528587
[TBL] [Abstract][Full Text] [Related]
22. Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.
Masri B; Salahpour A; Didriksen M; Ghisi V; Beaulieu JM; Gainetdinov RR; Caron MG
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13656-61. PubMed ID: 18768802
[TBL] [Abstract][Full Text] [Related]
23. Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia.
Langlois X; Megens A; Lavreysen H; Atack J; Cik M; te Riele P; Peeters L; Wouters R; Vermeire J; Hendrickx H; Macdonald G; De Bruyn M
J Pharmacol Exp Ther; 2012 Jul; 342(1):91-105. PubMed ID: 22490380
[TBL] [Abstract][Full Text] [Related]
24. Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits.
Trossbach SV; Bader V; Hecher L; Pum ME; Masoud ST; Prikulis I; Schäble S; de Souza Silva MA; Su P; Boulat B; Chwiesko C; Poschmann G; Stühler K; Lohr KM; Stout KA; Oskamp A; Godsave SF; Müller-Schiffmann A; Bilzer T; Steiner H; Peters PJ; Bauer A; Sauvage M; Ramsey AJ; Miller GW; Liu F; Seeman P; Brandon NJ; Huston JP; Korth C
Mol Psychiatry; 2016 Nov; 21(11):1561-1572. PubMed ID: 26754951
[TBL] [Abstract][Full Text] [Related]
25. Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic Treatment.
Weïwer M; Xu Q; Gale JP; Lewis M; Campbell AJ; Schroeder FA; Van de Bittner GC; Walk M; Amaya A; Su P; D Ordevic L; Sacher JR; Skepner A; Fei D; Dennehy K; Nguyen S; Faloon PW; Perez J; Cottrell JR; Liu F; Palmer M; Pan JQ; Hooker JM; Zhang YL; Scolnick E; Wagner FF; Holson EB
ACS Chem Biol; 2018 Apr; 13(4):1038-1047. PubMed ID: 29485852
[TBL] [Abstract][Full Text] [Related]
26. Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.
Urs NM; Gee SM; Pack TF; McCorvy JD; Evron T; Snyder JC; Yang X; Rodriguiz RM; Borrelli E; Wetsel WC; Jin J; Roth BL; O'Donnell P; Caron MG
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8178-E8186. PubMed ID: 27911814
[TBL] [Abstract][Full Text] [Related]
27. Dopamine D2 heteroreceptor complexes and their receptor-receptor interactions in ventral striatum: novel targets for antipsychotic drugs.
Fuxe K; Borroto-Escuela DO; Tarakanov AO; Romero-Fernandez W; Ferraro L; Tanganelli S; Perez-Alea M; Di Palma M; Agnati LF
Prog Brain Res; 2014; 211():113-39. PubMed ID: 24968778
[TBL] [Abstract][Full Text] [Related]
28. G protein-coupled receptor kinase 6/β-arrestin 2 system in a rat model of dopamine supersensitivity psychosis.
Oda Y; Tadokoro S; Takase M; Kanahara N; Watanabe H; Shirayama Y; Hashimoto K; Iyo M
J Psychopharmacol; 2015 Dec; 29(12):1308-13. PubMed ID: 26174132
[TBL] [Abstract][Full Text] [Related]
29. Neurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and beta-arrestin1-dependent mechanism.
Thibault D; Albert PR; Pineyro G; Trudeau LÉ
J Biol Chem; 2011 Mar; 286(11):9174-84. PubMed ID: 21233215
[TBL] [Abstract][Full Text] [Related]
30. Antipsychotic-like effects of a neurotensin receptor type 1 agonist.
Vadnie CA; Ayers-Ringler J; Oliveros A; Abulseoud OA; Choi S; Hitschfeld MJ; Choi DS
Behav Brain Res; 2016 May; 305():8-17. PubMed ID: 26909848
[TBL] [Abstract][Full Text] [Related]
31. Transient and rapid activation of Akt/GSK-3β and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens.
Salles MJ; Hervé D; Rivet JM; Longueville S; Millan MJ; Girault JA; Mannoury la Cour C
J Neurochem; 2013 May; 125(4):532-44. PubMed ID: 23410496
[TBL] [Abstract][Full Text] [Related]
32. Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice.
Xu R; Hranilovic D; Fetsko LA; Bucan M; Wang Y
Mol Psychiatry; 2002; 7(10):1075-82. PubMed ID: 12476322
[TBL] [Abstract][Full Text] [Related]
33. Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model.
Pogorelov VM; Nomura J; Kim J; Kannan G; Ayhan Y; Yang C; Taniguchi Y; Abazyan B; Valentine H; Krasnova IN; Kamiya A; Cadet JL; Wong DF; Pletnikov MV
Neuropharmacology; 2012 Mar; 62(3):1242-51. PubMed ID: 21315744
[TBL] [Abstract][Full Text] [Related]
34. The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review.
Dahoun T; Trossbach SV; Brandon NJ; Korth C; Howes OD
Transl Psychiatry; 2017 Jan; 7(1):e1015. PubMed ID: 28140405
[TBL] [Abstract][Full Text] [Related]
35. The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats.
Alimohamad H; Sutton L; Mouyal J; Rajakumar N; Rushlow WJ
J Neurochem; 2005 Oct; 95(2):513-25. PubMed ID: 16144542
[TBL] [Abstract][Full Text] [Related]
36. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
[TBL] [Abstract][Full Text] [Related]
37. Genetic inactivation of GSK3α rescues spine deficits in Disc1-L100P mutant mice.
Lee FH; Kaidanovich-Beilin O; Roder JC; Woodgett JR; Wong AH
Schizophr Res; 2011 Jun; 129(1):74-9. PubMed ID: 21498050
[TBL] [Abstract][Full Text] [Related]
38. d-Serine administration affects nitric oxide synthase 1 adaptor protein and DISC1 expression in sex-specific manner.
Svane KC; Asis EK; Omelchenko A; Kunnath AJ; Brzustowicz LM; Silverstein SM; Firestein BL
Mol Cell Neurosci; 2018 Jun; 89():20-32. PubMed ID: 29601869
[TBL] [Abstract][Full Text] [Related]
39. Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis.
Kusumi I; Boku S; Takahashi Y
Psychiatry Clin Neurosci; 2015 May; 69(5):243-58. PubMed ID: 25296946
[TBL] [Abstract][Full Text] [Related]
40. Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs.
Lipska BK; Peters T; Hyde TM; Halim N; Horowitz C; Mitkus S; Weickert CS; Matsumoto M; Sawa A; Straub RE; Vakkalanka R; Herman MM; Weinberger DR; Kleinman JE
Hum Mol Genet; 2006 Apr; 15(8):1245-58. PubMed ID: 16510495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
